SILO PHARMA, INC. Total Contract Liability
SILO PHARMA, INC. (SILO) had Total Contract Liability of $3.35 thousand as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-03-28
- 2024-12-31: Contract with Customer, Liability $3.35K.
- 2024-09-30: Contract with Customer, Liability $2.51K.
- 2024-06-30: Contract with Customer, Liability $1.68K.
- 2023-12-31: Contract with Customer, Liability $3.35K; Contract with Customer, Liability as first filed $26.61K.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2024-12-31 | $3.35K 10-K · filed 2025-03-28 | |
| 2024-09-30 | $2.51K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.68K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $3.35K 10-K · filed 2025-03-28 | $26.61K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |